Ying Liu, Cun-Yu Lu, Yi Zheng, Yu-Min Zhang, Ling-ling Qian, Ku-lin Li, Gary Tse, Ru-Xing Wang, Tong Liu
{"title":"血管紧张素受体-肾素抑制剂在糖尿病并发症中的作用","authors":"Ying Liu, Cun-Yu Lu, Yi Zheng, Yu-Min Zhang, Ling-ling Qian, Ku-lin Li, Gary Tse, Ru-Xing Wang, Tong Liu","doi":"10.4239/wjd.v15.i5.867","DOIUrl":null,"url":null,"abstract":"Diabetes mellitus is a prevalent disorder with multi-system manifestations, causing a significant burden in terms of disability and deaths globally. Angio-tensin receptor-neprilysin inhibitor (ARNI) belongs to a class of medications for treating heart failure, with the benefits of reducing hospitalization rates and mortality. This review mainly focuses on the clinical and basic investigations related to ARNI and diabetic complications, discussing possible physiological and molecular mechanisms, with insights for future applications.","PeriodicalId":509005,"journal":{"name":"World Journal of Diabetes","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Role of angiotensin receptor-neprilysin inhibitor in diabetic complications\",\"authors\":\"Ying Liu, Cun-Yu Lu, Yi Zheng, Yu-Min Zhang, Ling-ling Qian, Ku-lin Li, Gary Tse, Ru-Xing Wang, Tong Liu\",\"doi\":\"10.4239/wjd.v15.i5.867\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Diabetes mellitus is a prevalent disorder with multi-system manifestations, causing a significant burden in terms of disability and deaths globally. Angio-tensin receptor-neprilysin inhibitor (ARNI) belongs to a class of medications for treating heart failure, with the benefits of reducing hospitalization rates and mortality. This review mainly focuses on the clinical and basic investigations related to ARNI and diabetic complications, discussing possible physiological and molecular mechanisms, with insights for future applications.\",\"PeriodicalId\":509005,\"journal\":{\"name\":\"World Journal of Diabetes\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"World Journal of Diabetes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4239/wjd.v15.i5.867\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4239/wjd.v15.i5.867","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Role of angiotensin receptor-neprilysin inhibitor in diabetic complications
Diabetes mellitus is a prevalent disorder with multi-system manifestations, causing a significant burden in terms of disability and deaths globally. Angio-tensin receptor-neprilysin inhibitor (ARNI) belongs to a class of medications for treating heart failure, with the benefits of reducing hospitalization rates and mortality. This review mainly focuses on the clinical and basic investigations related to ARNI and diabetic complications, discussing possible physiological and molecular mechanisms, with insights for future applications.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
